Healthcare Innovation Sparks Oracle’s (ORCL) Growth - InvestingChannel

Healthcare Innovation Sparks Oracle’s (ORCL) Growth

Oracle (ORCL) is making bold moves in AI and health. If the company continues with its unique AI-driven database solutions as well as healthcare offerings expansions, it will be a company to watch.

Oracle Corporation is a multinational technology company that specializes in database software, cloud computing, and enterprise software solutions. Founded in 1977 and headquartered in Austin, Texas, Oracle is unique in its industry for its comprehensive suite of integrated cloud applications and platform services, which support businesses in various sectors with robust data management and analytics capabilities.

16 Most Technologically Advanced Countries in the World in 2017

Oracle’s key products are the Oracle Database, Oracle Cloud Infrastructure, ERP software, CRM solutions, HCM software, and middleware products. The sources of revenue are from cloud subscriptions, software license fees, hardware sales, and consulting services.

The key products of Oracle include the Oracle Database, Oracle Cloud Infrastructure, ERP software, CRM solutions, HCM software, and middleware products. Revenue sources come from cloud subscriptions, software license fees, hardware sales, and consulting services.

Oracle addresses a wide range of customers, from big business to the government and smaller businesses across different industries including banking, healthcare, retail, and telecommunication. The target end market consists of organizations aiming to improve their operations by developing the use of more complex technology solutions that advance data management, enhance operational efficiency, and foster digital transformation.

Recent focuses on AI and healthcare have made Oracle grow impressively. The company’s data-driven solutions based on artificial intelligence are revolutionizing large language model training, and with Oracle Health, the company is trying to tackle the fragmentation in U.S. healthcare databases.

With innovative tools such as the Clinical Digital Assistant and new AI-driven EHR platforms, it is improving patient care as well as doctor-patient interactions. The acquisition of Cerner further strengthens its push, combining Cerner’s healthcare expertise with enterprise technology from Oracle.

Equally impressive is the financial strength, as cloud revenue grew 21% YoY in its most recent quarterly result. Its ability to merge AI and healthcare has created a competitive advantage, one that competitors such as Epic Systems cannot easily duplicate. With solutions ranging from solving real healthcare challenges in the reduction of physician burnout to speeding up recruitment, Oracle is well set up to dominate this space.

I am bullish on Oracle on account of its strategic plays in AI and healthcare. The company is well poised to benefit from two of the fastest-growing industries, hence providing long-term growth. Strong financials along with a clear path to progress make Oracle a very safe bet for investors in search of sustained value.

ORCL almost made it to our latest list of the 31 Most Popular Stocks Among Hedge Funds. As per our database, 91 hedge fund portfolios held ORCL at the end of the second quarter which was 93 in the previous quarter. While we acknowledge the potential of ORCL as a leading AI investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as ORCL but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: $30 Trillion Opportunity: 15 Best Humanoid Robot Stocks to Buy According to Morgan Stanley and Jim Cramer Says NVIDIA ‘Has Become A Wasteland’.

Disclosure: None. This article was originally published at Insider Monkey.

Related posts

Advisors in Focus- January 6, 2021

Gavin Maguire

Advisors in Focus- February 15, 2021

Gavin Maguire

Advisors in Focus- February 22, 2021

Gavin Maguire

Advisors in Focus- February 28, 2021

Gavin Maguire

Advisors in Focus- March 18, 2021

Gavin Maguire

Advisors in Focus- March 21, 2021

Gavin Maguire